Rce1 deficiency accelerates the development of K-RAS-induced myeloproliferative disease - Wikidata - awgldk - TriplyDB

Rce1 deficiency accelerates the development of K-RAS-induced myeloproliferative disease

Rce1 deficiency accelerates the development of K-RAS-induced myeloproliferative disease

http://www.wikidata.org/entity/Q35615842

about

Mechanism of farnesylated CAAX protein processing by the intramembrane protease Rce1 Ras history: The saga continues.Palmitoylation of oncogenic NRAS is essential for leukemogenesis.RAS-converting enzyme 1-mediated endoproteolysis is required for trafficking of rod phosphodiesterase 6 to photoreceptor outer segments Drugging the undruggable RAS: Mission possible?8-Hydroxyquinoline-based inhibitors of the Rce1 protease disrupt Ras membrane localization in human cells.Inhibition of Ras for cancer treatment: the search continues.Divergent roles of CAAX motif-signaled posttranslational modifications in the regulation and subcellular localization of Ral GTPases.Modelling oncogenic Ras/Raf signalling in the mouse.Targeting oncogenic Ras signaling in hematologic malignancies.Inactivating Icmt ameliorates K-RAS-induced myeloproliferative disease.A RAS renaissance: emerging targeted therapies for KRAS-mutated non-small cell lung cancer.Regulating the regulator: post-translational modification of RAS Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?Therapeutic strategies for targeting ras proteins.Posttranslational Modifications of RAS Proteins.Rce1: mechanism and inhibition.Rce1 expression in renal cell carcinoma and its regulatory effect on 786-O cell apoptosis through endoplasmic reticulum stress.

P2860

Q27680718-1647A46C-DB8E-41D3-9D70-FFF731C3E18B Q30404024-C4187C72-AC8C-4F7A-8FE0-AF7E5FE3A2D1 Q33839862-B5FFCF21-B016-440C-9E42-221FF5B22E27 Q35008463-487CCDB7-3110-43E0-A417-6C1B9DD7D5DE Q35163434-4D42D512-2B34-4CD3-8FF1-93EE2457EC6F Q35878817-43113C86-7533-416E-9954-448C3094D3D5 Q35944601-CA9C9AE1-E40B-4560-8D5C-422363964CB3 Q36050056-ADA4B643-8BF1-428C-A7C5-EB9C53C5C990 Q36076132-A53A56BC-35CA-4074-9E5E-CA4E91B49FCA Q36352506-667AE422-7780-49D4-8E29-133F9A4D8521 Q36835230-511B00B2-791C-4672-B9BE-D3D1290E554A Q37724940-FB179F0C-7C11-4B3E-8478-98EDEDA2C692 Q37970568-6C64C407-8E90-49EA-978B-F3F70B8FFDD8 Q38423044-7F2FF168-74A3-454D-BD61-F2313977CBEB Q39262217-05752D88-F338-4031-A8EB-75D73BB97430 Q47223139-CDEF87D7-FF54-47DA-A613-EBDD802A514F Q50102683-D8A3C8ED-7DA8-4E5A-A5FF-B9F58C41EBFB Q51153452-6C993961-7516-411B-BEE0-69B388CC9AFA

P2860

Rce1 deficiency accelerates the development of K-RAS-induced myeloproliferative disease

http://www.wikidata.org/entity/Q35615842

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Rce1 deficiency accelerates the development of K-RAS-induced myeloproliferative disease

@ast

Rce1 deficiency accelerates the development of K-RAS-induced myeloproliferative disease

@en

type

label

Rce1 deficiency accelerates the development of K-RAS-induced myeloproliferative disease

@ast

Rce1 deficiency accelerates the development of K-RAS-induced myeloproliferative disease

@en

prefLabel

Rce1 deficiency accelerates the development of K-RAS-induced myeloproliferative disease

@ast

Rce1 deficiency accelerates the development of K-RAS-induced myeloproliferative disease

@en

P1433

Q35615842-09FFB783-1054-4E54-A800-6169171C8D5E

P1476

Q35615842-266A20F1-416C-4854-9725-534A0BD24DC6

P2093

Q35615842-432D92C1-B0E1-47AC-A38F-D85806F64AB0

Q35615842-6227369E-93C7-4C1A-A4A9-84768B65B75C

Q35615842-7DD0424C-D30A-4239-B68F-65B4CAEB7905

Q35615842-BB33923D-42A4-4A96-8902-964A7813EE45

Q35615842-C3594578-238A-4132-B23E-00EDD709E0F4

Q35615842-CC7F0047-2DB8-4D78-A607-76495E88ECF2

P2860

Q35615842-11ACA3EB-8F11-44BE-BBD4-45803039B90D

Q35615842-209AAE5F-01C3-4E6E-8C2D-3281727E2565

Q35615842-25EFF495-FE4A-4A38-9ADA-84268E964AF7

Q35615842-2698EF1E-B852-4E97-B705-D074E1277C9D

Q35615842-270280DA-CAA3-4C65-87CA-1F439C6BCF95

Q35615842-27582572-BF85-4A18-A799-5B1F4F7DEB69

Q35615842-30FC9A69-B68E-4438-B384-AF7E55492299

Q35615842-4A918134-12A6-4202-AFB2-4E2285F2779A

Q35615842-50BC03D6-D835-4CEC-98B9-5FC877DBB1D8

Q35615842-833593CD-B949-4882-9855-AF7ED3C915EE

P304

Q35615842-49278A73-B117-4B95-94BC-C199678D00F4

P31

Q35615842-76F4BFBE-A772-45B1-B6B8-9DCD72C33459

P356

Q35615842-69CB7E67-5EA9-40E7-BAC2-57F529E6C804

P407

Q35615842-F27C9B67-AE30-4B9F-A20B-FE8AE88B43CF

P433

Q35615842-1508AE6C-8EB6-49F5-B376-8DD3BA3A8E0D

P478

Q35615842-0BD89006-03F7-4A10-98BC-0F90330B39D3

P50

Q35615842-70058359-C935-4CCF-89DF-8648AA3BF89E

Q35615842-79CD36DE-5224-49AC-8761-EC3B501AB7FD

Q35615842-FD27FA3F-7D26-4C4B-94C2-663AAE5C16E5

P577

Q35615842-DE6989DD-338C-47CF-AB81-3D43E8569003

P5875

Q35615842-24C42C85-8AC2-4156-9B51-46C82AAE6BF3

P698

Q35615842-71FEBE13-4A63-41AE-A5BE-39A2B54D1C86

P932

Q35615842-9674701F-6CBA-40A4-8A28-E5DBF3F44D6B

P356

BLOOD-2006-05-024752

P1433

P1476

Rce1 deficiency accelerates the development of K-RAS-induced myeloproliferative disease

@en

P2093

Anna-Karin M Sjogren

http://www.w3.org/2001/XMLSchema#string

Annika M Wahlstrom

http://www.w3.org/2001/XMLSchema#string

Birgitta Swolin

http://www.w3.org/2001/XMLSchema#string

Briony A Cutts

http://www.w3.org/2001/XMLSchema#string

Christin Karlsson

http://www.w3.org/2001/XMLSchema#string

Martin O Bergo

http://www.w3.org/2001/XMLSchema#string

P2860

NF1 tumor suppressor gene function: narrowing the GAP

Disruption of the mouse Rce1 gene results in defective Ras processing and mislocalization of Ras within cells

Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder

ras oncogenes in human cancer: a review

Inducible gene targeting in mice

RAS and leukemia: from basic mechanisms to gene-directed therapy.

Selective inhibition of ras-transformed cell growth by a novel fatty acid-based chloromethyl ketone designed to target Ras endoprotease.

Absence of the CAAX endoprotease Rce1: effects on cell growth and transformation.

K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors.

ras and human tumors.

P304

763-768

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2006-05-024752

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Karin M Andersson

Stephen G. Young

P577

2006-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6817337

http://www.w3.org/2001/XMLSchema#string

P698

16973961

http://www.w3.org/2001/XMLSchema#string

P932

1785091

http://www.w3.org/2001/XMLSchema#string